BR102012008322B8 - low-ozone, ozone-depleting aerosol medicinal formulations - Google Patents
low-ozone, ozone-depleting aerosol medicinal formulationsInfo
- Publication number
- BR102012008322B8 BR102012008322B8 BR102012008322A BR102012008322A BR102012008322B8 BR 102012008322 B8 BR102012008322 B8 BR 102012008322B8 BR 102012008322 A BR102012008322 A BR 102012008322A BR 102012008322 A BR102012008322 A BR 102012008322A BR 102012008322 B8 BR102012008322 B8 BR 102012008322B8
- Authority
- BR
- Brazil
- Prior art keywords
- ozone
- low
- depleting
- medicinal formulations
- aerosol medicinal
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
formulações medicinais em aerossol que não debilitam a camada de ozônio e com baixo efeito estufa. os inaladores farmacêuticos pressurizados de dose medida estão demonstrando ter tuna composição livre de cfc e totalmente ou parcialmente livre de hfa, permitindo assim a fabricação de aerossóis medicinais que não provoquem efeitos nocivos à camada de ozônio da atmosfera e com efeito estufa baixo ou desprezível.low-ozone, non-ozone depleting aerosol medicinal formulations. Pressurized metered dose pharmaceutical inhalers are being shown to have a cfc-free and wholly or partially hfa-free composition, thus allowing the manufacture of medical aerosols that do not cause harmful effects to the ozone layer of the atmosphere and have a low or negligible greenhouse effect.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/052,054 | 2011-03-19 | ||
US13/052,054 US20120207685A1 (en) | 2011-02-10 | 2011-03-19 | Non-ozone depleting medicinal formulations with low greenhouse effect |
Publications (3)
Publication Number | Publication Date |
---|---|
BR102012008322A2 BR102012008322A2 (en) | 2015-08-04 |
BR102012008322B1 BR102012008322B1 (en) | 2019-01-15 |
BR102012008322B8 true BR102012008322B8 (en) | 2019-02-19 |
Family
ID=49552950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR102012008322A BR102012008322B8 (en) | 2011-03-19 | 2012-03-19 | low-ozone, ozone-depleting aerosol medicinal formulations |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR085443A1 (en) |
BR (1) | BR102012008322B8 (en) |
-
2012
- 2012-03-19 AR ARP120100894 patent/AR085443A1/en not_active Application Discontinuation
- 2012-03-19 BR BR102012008322A patent/BR102012008322B8/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
BR102012008322B1 (en) | 2019-01-15 |
AR085443A1 (en) | 2013-10-02 |
BR102012008322A2 (en) | 2015-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1120605T1 (en) | DRY POWDER PREPARATION INCLUDING A PHOSPHODIESTERATION INHIBITOR | |
EA201290375A1 (en) | COMBINATION THERAPY COPD | |
CL2015000486A1 (en) | Nicotine Composition | |
BR112014029738A2 (en) | mixed rods for use in aerosol generating articles | |
UY30139A1 (en) | PHARMACEUTICAL FORMULATION FOR AEROSOLS WITH TWO OR MORE ACTIVE PRINCIPLES AND AT LEAST A TENSIOACTIVE SUBSTANCE | |
PE20160543A1 (en) | DRY POWDER INHALER CONTAINING FLUTICASONE AND SALMETEROL | |
IN2014DN06501A (en) | ||
TR201000680A2 (en) | Pharmaceutical compositions containing tiotropium, formoterol and budesonide | |
PH12015502593A1 (en) | COMPOSITIONS, METHODS and SYSTEMS FOR RESPIRATORY DELIVERY OF THREE OR MORE ACTIVE AGENTS | |
UY34359A (en) | ? MULTIPLE SCLEROSIS TREATMENT WITH COMBINATION OF LAQUINIMOD AND INTERFERÓN-BETA ?. | |
MX357619B (en) | An inhaler comprising a tiotropium-containing-composition. | |
BR112015027017A2 (en) | inhalable pharmaceutical compositions and inhaler devices containing the same | |
ECSP14013275A (en) | DERIVATIVES OF ESTRA-1,3,5 (10), 16-TETRAEN-3-CARBOXAMIDE, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM, AS WELL AS THEIR USE FOR THE PREPARATION OF MEDICINES | |
CR20150007A (en) | DERIVATIVES OF ESTRA-1,3,5 (10), 16-TETRAENE 3-SUBSTITUTES, METHODS FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS CONTAINING THEM, AS WELL AS THEIR USE FOR THE PREPARATION OF MEDICINES | |
BR112014018767A8 (en) | FUSED PYRROLDICARBOXAMIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITION INCLUDING THEM | |
WO2011076841A3 (en) | Combination therapy for copd | |
TN2012000261A1 (en) | Aerosol formulation for copd | |
BR112017023351A2 (en) | fragile matrix multidrug compositions | |
CL2012003265A1 (en) | Tamarind seed polysaccharide for use in the treatment of infectious diseases; pharmaceutical and / or anti-inflammatory dermocosmetic composition containing said polysaccharide; use of a tamarind seed polysaccharide. | |
CY1117596T1 (en) | PHARMACEUTICAL AIRPORT COMPOSITIONS OF FORMOTEROL AND DIPROPIONAL VEHICLE | |
MX2015009891A (en) | Pharmaceutical compositions comprising multi-component crystalline particles suitable for use in inhalation therapy. | |
CL2012000947A1 (en) | Metered dose inhalation suspension formulation comprising formoterol fumarate dihydrate and fluticasone propionate and microlin sodium in an hfa propellant; pharmaceutical composition; a product; use of 0.01 to 0.1% cromolyn sodium, useful in asthma and rhinitis. | |
BR102012008322B8 (en) | low-ozone, ozone-depleting aerosol medicinal formulations | |
AR089101A1 (en) | NASAL FORMULATION | |
MX2014001940A (en) | Pharmaceutical aerosol product for administration by oral or nasal inhalation. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B03A | Publication of an application: publication of a patent application or of a certificate of addition of invention | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law | ||
B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) | ||
B07A | Technical examination (opinion): publication of technical examination (opinion) | ||
B09A | Decision: intention to grant | ||
B16A | Patent or certificate of addition of invention granted |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 19/03/2012, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 19/03/2012, OBSERVADAS AS CONDICOES LEGAIS. (CO) REFERENTE A RPI 2506 DE 15/01/2019,QUANTO AO ITEM (72). |